Scientific Sessions 2025  /  TCT at AHA: Heart Team in Action: Arrhythmogenic Mitral Valve Prolapse: Predicting Risk, Protecting Patients, and Personalizing Treatment  /  Mitral Valve Surgery in Arrhythmogenic Mitral Regurgitation: Special Considerations
Logo

American Heart Association

  44
  0

Final ID:

Mitral Valve Surgery in Arrhythmogenic Mitral Regurgitation: Special Considerations

  • Borger, Michael  ( Leipzig Heart Center , Leipzig , Germany )
  • Adams, David  ( MOUNT SINAI MEDICAL CENTER , New York , New York , United States )
  • Gillinov, A Marc  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Nguyen, Tom  ( Miami Cardiac and Vascular Inst , Miami , Florida , United States )
  • Ramzy, Danny  ( UTHealth Houston , Houston , Texas , United States )
    • Author Disclosures:
    Michael Borger: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Edwards Lifesciences -- my hospital receives speakers' honoria and/or consulting fees on my behalf:Active (exists now) ; Other (please indicate in the box next to the company name):Artivion -- my hospital receives speakers' honoria and/or consulting fees on my behalf:Active (exists now) ; Other (please indicate in the box next to the company name):Abbott -- my hospital receives speakers' honoria and/or consulting fees on my behalf:Active (exists now) ; Other (please indicate in the box next to the company name):Medtronic -- my hospital receives speakers' honoria and/or consulting fees on my behalf:Active (exists now) | David Adams: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Edwards Lifesciences, Medtronic:Active (exists now) | A MARC GILLINOV: No Answer | Tom Nguyen: DO NOT have relevant financial relationships | Danny Ramzy: DO have relevant financial relationships ; Speaker:Abiomed:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Heart Team in Action: Arrhythmogenic Mitral Valve Prolapse: Predicting Risk, Protecting Patients, and Personalizing Treatment

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Case Presentation of Arrythmic Mitral Valve Prolapse

Costa Ana Claudia, Adams David, Nguyen Tom, Ramzy Danny

Defining the Role of Ablation Therapies and ICD in Arrythmic Mitral Valve Prolapse

Miller Marc, Sabbag Avi, Delling Francesca

More abstracts from these authors:
Case Presentation of Arrythmic Mitral Valve Prolapse

Costa Ana Claudia, Adams David, Nguyen Tom, Ramzy Danny

Surgical Advances: Minimally Invasive and Robotic Mitral Repair is PrimeTime

Ramzy Danny, Mick Stephanie, Gillinov A Marc, Nguyen Tom

You have to be authorized to contact abstract author. Please, Login
Not Available